GABAPENTIN | A217995 | RISING PHARMA HOLDINGS INC
Highest NADAC/Unit
$0.0963
per ea
Lowest NADAC/Unit
$0.0668
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16571011701GABAPENTIN 800 MG TABLET | $0.0963 | EA | Generic | — | 2026-06-17 |
| 16571011750GABAPENTIN 800 MG TABLET | $0.0963 | EA | Generic | — | 2026-06-17 |
| 16571022601GABAPENTIN 600 MG TABLET | $0.0668 | EA | Generic | — | 2026-06-17 |
| 16571022650GABAPENTIN 600 MG TABLET | $0.0668 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.